ECHOSTAR CORP-A (SATS) Fundamental Analysis & Valuation

NASDAQ:SATS • US2787681061

Current stock price

124.9 USD
+5.12 (+4.27%)
Last:

This SATS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. SATS Profitability Analysis

1.1 Basic Checks

  • In the past year SATS was profitable.
  • In the past year SATS has reported a negative cash flow from operations.
  • In multiple years SATS reported negative net income over the last 5 years.
  • Of the past 5 years SATS 4 years had a positive operating cash flow.
SATS Yearly Net Income VS EBIT VS OCF VS FCFSATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B

1.2 Ratios

  • SATS has a worse Return On Assets (-33.70%) than 74.73% of its industry peers.
  • With a Return On Equity value of -251.43%, SATS is not doing good in the industry: 75.82% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROIC N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
SATS Yearly ROA, ROE, ROICSATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • With a Gross Margin value of 25.82%, SATS is not doing good in the industry: 64.84% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of SATS has declined.
  • The Profit Margin and Operating Margin are not available for SATS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
SATS Yearly Profit, Operating, Gross MarginsSATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. SATS Health Analysis

2.1 Basic Checks

  • SATS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SATS has been increased compared to 1 year ago.
  • SATS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SATS has a worse debt to assets ratio.
SATS Yearly Shares OutstandingSATS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SATS Yearly Total Debt VS Total AssetsSATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • SATS has an Altman-Z score of 0.60. This is a bad value and indicates that SATS is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.60, SATS is in line with its industry, outperforming 45.05% of the companies in the same industry.
  • SATS has a Debt/Equity ratio of 3.24. This is a high value indicating a heavy dependency on external financing.
  • SATS's Debt to Equity ratio of 3.24 is on the low side compared to the rest of the industry. SATS is outperformed by 73.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Altman-Z 0.6
ROIC/WACCN/A
WACC9.14%
SATS Yearly LT Debt VS Equity VS FCFSATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.42 indicates that SATS may have some problems paying its short term obligations.
  • With a Current ratio value of 0.42, SATS is not doing good in the industry: 80.22% of the companies in the same industry are doing better.
  • SATS has a Quick Ratio of 0.42. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SATS has a worse Quick ratio (0.38) than 82.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.38
SATS Yearly Current Assets VS Current LiabilitesSATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SATS Growth Analysis

3.1 Past

  • SATS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1628.89%, which is quite impressive.
  • Measured over the past years, SATS shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.00% on average per year.
  • Looking at the last year, SATS shows a decrease in Revenue. The Revenue has decreased by -5.18% in the last year.
  • SATS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.37% yearly.
EPS 1Y (TTM)1628.89%
EPS 3Y49%
EPS 5YN/A
EPS Q2Q%-441.46%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%

3.2 Future

  • The Earnings Per Share is expected to decrease by -51.55% on average over the next years. This is quite bad
  • SATS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.00% yearly.
EPS Next Y-139.66%
EPS Next 2Y-41.63%
EPS Next 3Y-67.81%
EPS Next 5Y-51.55%
Revenue Next Year-3.41%
Revenue Next 2Y-2.74%
Revenue Next 3Y-2.61%
Revenue Next 5Y-2%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SATS Yearly Revenue VS EstimatesSATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
SATS Yearly EPS VS EstimatesSATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -10 -20 -30 -40

More info and screens

Find the best growth stocksShow best growing peers

1

4. SATS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.15, which indicates a rather expensive current valuation of SATS.
  • 74.73% of the companies in the same industry are more expensive than SATS, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.54. SATS is valued slightly cheaper when compared to this.
  • SATS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 18.15
Fwd PE N/A
SATS Price Earnings VS Forward Price EarningsSATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • SATS's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.81
SATS Per share dataSATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • SATS's earnings are expected to decrease with -67.81% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.63%
EPS Next 3Y-67.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SATS Dividend Analysis

5.1 Amount

  • No dividends for SATS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SATS Fundamentals: All Metrics, Ratios and Statistics

ECHOSTAR CORP-A

NASDAQ:SATS (4/30/2026, 2:08:38 PM)

124.9

+5.12 (+4.27%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Industry Strength37.89
Industry Growth4.35
Earnings (Last)03-02
Earnings (Next)05-07
Inst Owners98.44%
Inst Owner Change0.24%
Ins Owners12.15%
Ins Owner Change1.92%
Market Cap36.08B
Revenue(TTM)15.00B
Net Income(TTM)-14.50B
Analysts76.36
Price Target120.96 (-3.15%)
Short Float %26.05%
Short Ratio5.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)339.66%
Min EPS beat(2)-463.29%
Max EPS beat(2)1142.6%
EPS beat(4)2
Avg EPS beat(4)174.08%
Min EPS beat(4)-463.29%
Max EPS beat(4)1142.6%
EPS beat(8)3
Avg EPS beat(8)88.21%
EPS beat(12)6
Avg EPS beat(12)20.43%
EPS beat(16)8
Avg EPS beat(16)28.88%
Revenue beat(2)0
Avg Revenue beat(2)-3.28%
Min Revenue beat(2)-5.46%
Max Revenue beat(2)-1.09%
Revenue beat(4)0
Avg Revenue beat(4)-3.22%
Min Revenue beat(4)-5.46%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-2.77%
Revenue beat(12)1
Avg Revenue beat(12)-3.2%
Revenue beat(16)4
Avg Revenue beat(16)-2.11%
PT rev (1m)2.31%
PT rev (3m)-0.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.17%
EPS NY rev (1m)25.98%
EPS NY rev (3m)20.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)-0.77%
Valuation
Industry RankSector Rank
PE 18.15
Fwd PE N/A
P/S 2.4
P/FCF N/A
P/OCF N/A
P/B 6.26
P/tB 6.32
EV/EBITDA 37.81
EPS(TTM)6.88
EY5.51%
EPS(NY)-2.73
Fwd EYN/A
FCF(TTM)-3.69
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS51.94
BVpS19.96
TBVpS19.77
PEG (NY)N/A
PEG (5Y)N/A
Graham Number55.5848 (-55.5%)
Profitability
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.82%
FCFM N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
F-Score3
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Debt/EBITDA 12.49
Cap/Depr 60.91%
Cap/Sales 6.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.38
Altman-Z 0.6
F-Score3
WACC9.14%
ROIC/WACCN/A
Cap/Depr(3y)111.73%
Cap/Depr(5y)101.51%
Cap/Sales(3y)11.48%
Cap/Sales(5y)15.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1628.89%
EPS 3Y49%
EPS 5YN/A
EPS Q2Q%-441.46%
EPS Next Y-139.66%
EPS Next 2Y-41.63%
EPS Next 3Y-67.81%
EPS Next 5Y-51.55%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%
Revenue Next Year-3.41%
Revenue Next 2Y-2.74%
Revenue Next 3Y-2.61%
Revenue Next 5Y-2%
EBIT growth 1Y70.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.76%
EBIT Next 3Y32.04%
EBIT Next 5Y17.98%
FCF growth 1Y-263.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.93%
OCF growth 3YN/A
OCF growth 5YN/A

ECHOSTAR CORP-A / SATS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ECHOSTAR CORP-A?

ChartMill assigns a fundamental rating of 1 / 10 to SATS.


What is the valuation status of ECHOSTAR CORP-A (SATS) stock?

ChartMill assigns a valuation rating of 1 / 10 to ECHOSTAR CORP-A (SATS). This can be considered as Overvalued.


Can you provide the profitability details for ECHOSTAR CORP-A?

ECHOSTAR CORP-A (SATS) has a profitability rating of 1 / 10.


What is the valuation of ECHOSTAR CORP-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ECHOSTAR CORP-A (SATS) is 18.15 and the Price/Book (PB) ratio is 6.26.


How financially healthy is ECHOSTAR CORP-A?

The financial health rating of ECHOSTAR CORP-A (SATS) is 0 / 10.